Nuno Osório

Prof. Dr. Nuno Osório

ICVS/3B’s - PT Government Associate Laboratory, Braga/Guimarães, Portugal
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2020 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
CACarolina M. Andrade
Carolina M. Andrade
HFHannah Fleckenstein
Hannah Fleckenstein
RTRichard Thomson-Luque
Richard Thomson-Luque
SDSafiatou Doumbo
Safiatou Doumbo
NLNathalia F. Lima
Nathalia F. Lima
SPSilvia Portugal
Silvia Portugal

8 May 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
SGSamuel M. Gonçalves
Samuel M. Gonçalves
CDCláudio Duarte-Oliveira
Cláudio Duarte-Oliveira
CCCláudia F. Campos
Cláudia F. Campos
VAVishukumar AIMANIANDA
Vishukumar AIMANIANDA
RHRob ter Horst
Rob ter Horst
ACAgostinho Carvalho
Agostinho Carvalho
In response to infection, macrophages adapt their metabolism rapidly to enhance glycolysis and fuel specialized antimicrobial effector functions. Here we show that fungal melanin is an essential molecule required for the metabolic rewiring of macrophages during infection with the fungal pathogen Aspergillus fumigatus. Using pharmacological and genetic tools, we reveal a molecular link between calcium sequestration by melanin inside the phagosome and induction of glycolysis required for efficient innate immune responses. By remodeling the intracellular calcium machinery and impairing signaling via calmodulin, melanin drives an immunometabolic signaling axis towards glycolysis with activation of hypoxia-inducible factor 1 subunit alpha (HIF-1α) and phagosomal recruitment of mammalian target of rapamycin (mTOR). These data demonstrate a pivotal mechanism in the immunometabolic regulation of macrophages during fungal infection and highlight the metabolic repurposing of immune cells as a potential therapeutic strategy.

15 September 2007 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
BABruno Almeida
Bruno Almeida
SBSabrina Büttner
Sabrina Büttner
SOSteffen Ohlmeier
Steffen Ohlmeier
ASAlexandra Silva
Alexandra Silva
AMAna Mesquita
Ana Mesquita
Paula LudovicoPaula Ludovico
Paula Ludovico
Nitric oxide (NO) is a small molecule with distinct roles in diverse physiological functions in biological systems, among them the control of the apoptotic signalling cascade. By combining proteomic, genetic and biochemical approaches we demonstrate that NO and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) are crucial mediators of yeast apoptosis. Using indirect methodologies and a NO-selective electrode, we present results showing that H2O2-induced apoptotic cells synthesize NO that is associated to a nitric oxide synthase (NOS)-like activity as demonstrated by the use of a classical NOS kit assay. Additionally, our results show that yeast GAPDH is a target of extensive proteolysis upon H2O2-induced apoptosis and undergoes S-nitrosation. Blockage of NO synthesis with Nω-nitro-L-arginine methyl ester leads to a decrease of GAPDH S-nitrosation and of intracellular reactive oxygen species (ROS) accumulation, increasing survival. These results indicate that NO signalling and GAPDH S-nitrosation are linked with H2O2-induced apoptotic cell death. Evidence is presented showing that NO and GAPDH S-nitrosation also mediate cell death during chronological life span pointing to a physiological role of NO in yeast apoptosis.

23 April 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
JSJeremy Sousa
Jeremy Sousa
BCBaltazar Cá
Baltazar Cá
AMAna Raquel Maceiras
Ana Raquel Maceiras
LSLuisa Simões-Costa
Luisa Simões-Costa
KFKaori L. Fonseca
Kaori L. Fonseca
MSMargarida Saraiva
Margarida Saraiva
Genetic diversity ofMycobacterium tuberculosisaffects immune responses and clinical outcomes of tuberculosis (TB). However, how bacterial diversity orchestrates immune responses to direct distinct TB severities is unknown. Here we study 681 patients with pulmonary TB and show thatM.tuberculosisisolates from cases with mild disease consistently induce robust cytokine responses in macrophages across multiple donors. By contrast, bacteria from patients with severe TB do not do so. Secretion of IL-1β is a good surrogate of the differences observed, and thus to classify strains as probable drivers of different TB severities. Furthermore, we demonstrate thatM.tuberculosisisolates that induce low levels of IL-1β production can evade macrophage cytosolic surveillance systems, including cGAS and the inflammasome. Isolates exhibiting this evasion strategy carry candidate mutations, generating sigA recognition boxes or affecting components of the ESX-1 secretion system. Therefore, we provide evidence thatM.tuberculosisstrains manipulate host-pathogen interactions to drive variable TB severities.

26 June 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JCJenny Carmona
Jenny Carmona
ACAndrea Cruz
Andrea Cruz
LMLucia Moreira-Teixeira
Lucia Moreira-Teixeira
CSCarole de Sousa
Carole de Sousa
JSJeremy Sousa
Jeremy Sousa
MSMargarida Saraiva
Margarida Saraiva
Tuberculosis associates with a wide spectrum of disease outcomes. The Beijing (Bj) lineage of Mycobacterium tuberculosis (Mtb) is suggested to be more virulent than other Mtb lineages and prone to elicit non-protective immune responses. However, highly heterogeneous immune responses were reported upon infection of innate immune cells with Bj strains or stimulation with their glycolipids. Using both in vitro and in vivo mouse models of infection, we here report that the molecular mechanism for this heterogeneity may be related to distinct TLR activations. Among this Mtb lineage, we found strains that preferentially activate TLR2, and others that also activate TLR4. Recognition of Mtb strains by TLR4 resulted in a distinct cytokine profile in vitro and in vivo, with specific production of type I IFN. We also uncover a novel protective role for TLR4 activation in vivo. Thus, our findings contribute to the knowledge of the molecular basis underlying how host innate immune cells handle different Mtb strains, in particular the intricate host-pathogen interaction with strains of the Mtb Bj lineage.

28 February 2013 in Molecular Biology and Evolution
Verified
Journal Article
Open access
PDF file
Nuno OsórioNuno Osório
Nuno Osório
Fernando RodriguesFernando Rodrigues
Fernando Rodrigues
SGSebastien Gagneux
Sebastien Gagneux
JPJorge Pedrosa
Jorge Pedrosa
MPMarta Pinto-Carbó
Marta Pinto-Carbó
MSMargarida Saraiva
Margarida Saraiva
Tuberculosis (TB) is a global health problem estimated to kill 1.4 million people per year. Recent advances in the genomics of the causative agents of TB, bacteria known as the Mycobacterium tuberculosis complex (MTBC), have allowed a better comprehension of its population structure and provided the foundation for molecular evolution analyses. These studies are crucial for a better understanding of TB, including the variation of vaccine efficacy and disease outcome, together with the emergence of drug resistance. Starting from the analysis of 73 publicly available genomes from all the main MTBC lineages, we have screened for evidences of positive selection, a set of 576 genes previously associated with drug resistance or encoding membrane proteins. As expected, because antibiotics constitute strong selective pressure, some of the codons identified correspond to the position of confirmed drug-resistance-associated substitutions in the genes embB, rpoB, and katG. Furthermore, we identified diversifying selection in specific codons of the genes Rv0176 and Rv1872c coding for MCE1-associated transmembrane protein and a putative l-lactate dehydrogenase, respectively. Amino acid sequence analyses showed that in Rv0176, sites undergoing diversifying selection were in a predicted antigen region that varies between “modern” lineages and “ancient” MTBC/BCG strains. In Rv1872c, some of the sites under selection are predicted to impact protein function and thus might result from metabolic adaptation. These results illustrate that diversifying selection in MTBC is happening as a consequence of both antibiotic treatment and other evolutionary pressures.